The current two-drug treatment for hepatitis C does not work as well as patients would like. Now, researchers have found that adding a third drug to the mix leads to better results.

Lack of health insurance coverage may affect hepatitis C patients' access to current antiviral treatments, according to a new study.

A study from South Korea has found a link between the Hepatitis A virus and patients with pre-existing chronic liver disease and identified the age group most at risk.

Scientists have created an antibody to remove the Hepatitis C virus from the bloodstream during liver transplant surgery in an effort to prevent re-infection of the organ, a problem that occurs in most cases.

Scientists find new ways to predict the efficiency of Hepatitis C treatments by singling out a particular protein that, in its abnormal form, impedes immune response instead of helping it.